Skip to main content
. 2014 Dec;23(134):469–475. doi: 10.1183/09059180.00007314

Figure 2.

Figure 2.

Treatment algorithm showing the class of recommendations and level of evidence for sequential combination therapy. PAH: pulmonary arterial hypertension; ERA: endothelin receptor antagonists; PDE-5i: phosphodiesterase type-5 inhibitor; sGCS: soluble guanine cyclase stimulator; BAS: balloon atrial septostomy. Reproduced from [10] with permission from the publisher.